Publication | Open Access

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

Surgical OncologyIntermediate-risk Rectal CancerRadiation TherapyGastrointestinal OncologyLate ToxicitiesMedicineSurgeryCancer TreatmentAccord 12/0405-Prodige 02OncologyRadiation Oncology